BioELife Corp Adds Michael Terpin to Advisory Board as Marketing & Public Relations Industry Expert - Seite 2

Terpin holds an MFA from SUNY at Buffalo and dual BA in journalism and English from Syracuse University, where he serves on the board of advisors at the top-ranked Newhouse School of Public Communications.  Terpin is also an investor and advisor to many blockchain, media and technology companies, including Aion, Polymath, Purse.io, ShapeShift, VideoCoin and WAX. He is a limited partner and senior advisor to Alphabit Fund (www.alphabit.fund), a Cayman Island registered digital currency fund. Terpin lives with his wife, Maxine, and three dogs in San Juan, Puerto Rico, where he received the first Act 22 investor decree granted to a blockchain industry investor. He, along with Gabriel Abed and Roger Ver, co-founded the Caribbean Blockchain Association in 2015.

Mr. Terpin’s vast experience will be integral to the development of effective communication for BioELife’s products and vision to help people fight pain & infection while reducing their dependency on opioids that have terrible side effects.  Further plans are under way to use Mr. Terpin and his teams to assist the Company with its Social Media, as well as Public Relations and news coverage particularly as BioELife (BioELife.com) expands its BioEDefense (www.BioEDefense.com) line of products that provide advanced protection from viral and bacterial contamination.

“I’ve had the pleasure of working with serial entrepreneur and corporate executive Greg Rotelli on dozens of innovative products and companies over the past 25 years,” said Terpin. “BioELife is in a good position to market a solid, innovative product line in health and medical markets that are exploding in volume.”

Gregory Rotelli, Chairman of the Board and President of BioELife stated “I have known Mike Terpin for many years and his experience and knowledge are vast and extensive. We are honored to have an expert of Michael Terpin’s caliber join our Advisory Board and assist our corporate communication and social media initiatives. His experience will provide immediate benefits as effective communication is paramount to our business as we grow.”

About the Company

BioELife Corp was created by successful pharmaceutical entrepreneurs dedicated to using nature’s resources to fight pain and infection while reducing the dependency on opioids and their terrible side effects. The Company is uniquely positioned to capitalize on the emerging Cannabinoid market that is growing at phenomenal rates and is expected to reach $20 Billion over the next five years. The Company has created a ‘seed to shelf’ value-added product development and marketing organization with direct contracts for raw materials, scientific proprietary formulation, manufacturing, and distribution of medically focused Cannabinoid products. Additionally, the Company has a BioEDefense line of products that provide advanced protection from viral and bacterial contamination.